Life Science Company News

Results 1 - 20 out of 500 displayed.
1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Angion Announces Phase 1b Trial of ANG-3070 in Patients with Idiopathic Pulmonary Fibrosis

Read more ››
By: GlobenewsWire - 16 May 2022

Valneva Receives Emergency Use Authorization from the United Arab Emirates for its Inactivated COVID-19 Vaccine

Read more ››
By: GlobenewsWire - 16 May 2022

ObsEva to Present at the H.C. Wainwright Global Investment 2022 Conference

Read more ››
By: GlobenewsWire - 16 May 2022

GeneQuantum Healthcare's Two Next Generation Bioconjugate Drugs, GQ1005 and GQ1007, Have Been Approved for Clinical Trials in Australia

Read more ››
By: PR Newswire Association LLC. - 16 May 2022

Antengene Announces Commercial Availability of XPOVIO® (Selinexor), for the Treatment of Relapsed/Refractory Multiple Myeloma, Prescribed for the First Time Across Mainland China

Read more ››
By: PR Newswire Association LLC. - 16 May 2022

Pocared Diagnostics, an Israeli rapid infectious diseases diagnostics leader, secures a EUR 22 million EIB backing for completion of the development and commercialization of its rapid testing system

Read more ››
By: PR Newswire Association LLC. - 16 May 2022

Zenas BioPharma Submits Investigational New Drug Application in China for ZB001 for the Treatment of Thyroid Eye Disease

Read more ››
By: GlobenewsWire - 16 May 2022

KemPharm Announces Strategic Acquisition of Arimoclomol from Orphazyme, Expanding its Rare CNS Diseases Pipeline

Read more ››
By: GlobenewsWire - 16 May 2022

UMP Purchases Advanced Medical Imaging Equipment and Facilities

Read more ››
By: PR Newswire Association LLC. - 16 May 2022

Inmagene Receives FDA IND Clearance for a Third Generation BTK Inhibitor Targeting Immunological Diseases

Read more ››
By: PR Newswire Association LLC. - 16 May 2022

Innovent Will Present Clinical Data of IBI110 (anti-LAG-3 monoclonal antibody) and Other Multiple Trials at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting

Read more ››
By: PR Newswire Association LLC. - 16 May 2022

Orphazyme A/S under In-Court-Restructuring to sell substantially all of its assets and business activities to KemPharm, Inc.

Read more ››
By: GlobenewsWire - 15 May 2022

ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Homology Medicines, Inc. Investors with Losses Exceeding $100K to Secure Counsel Before Important May 24 Deadline in Securities Class Action - FIXX

Read more ››
By: PR Newswire Association LLC. - 15 May 2022

Kintor Pharma Included in MSCI China Index

Read more ››
By: PR Newswire Association LLC. - 15 May 2022

Urologists Analyze Stewardship of Opioid and Antibiotic Prescribing

Read more ››
By: PR Newswire Association LLC. - 15 May 2022

VIDA Introduces New AI-Enabled Biomarker Services

Read more ››
By: PR Newswire Association LLC. - 15 May 2022

Avillion announces publication of positive full results from MANDALA Phase III trial of AstraZeneca's PT027 in asthma patients in the New England Journal of Medicine

Read more ››
By: PR Newswire Association LLC. - 15 May 2022

Boehringer Ingelheim's latest investigational treatment slowed lung function decline in people living with idiopathic pulmonary fibrosis

Read more ››
By: PR Newswire Association LLC. - 15 May 2022

Press Release: Sarclisa® (isatuximab) combination provides unprecedented median progression free survival in patients with relapsed multiple myeloma receiving a proteasome inhibitor therapy

Read more ››
By: GlobenewsWire - 15 May 2022

A Dental Practice That Focuses On Easing Dental Anxiety In Singapore

Read more ››
By: PR Newswire Association LLC. - 15 May 2022
Results 1 - 20 out of 500 displayed.
1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Enhance your business development with Biotechgate